跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 96,544 条关于
“BRCA-mutated ovarian cancer”
全部
96,544
临床试验
78,195
药物
2,358
机构
1,112
资讯
14,879
5年前
Comparative Analysis of PARP Inhibitors in BRCA-Mutated Ovarian Cancer Shows Similar Efficacy and Toxicity
6年前
PARP Inhibitors Show Similar Efficacy in BRCA-Mutated Ovarian Cancer, Cost-Effectiveness Varies
去年
Final ARIEL4 Trial Results Show Limited Benefit of Rucaparib in BRCA+ Ovarian Cancer
4个月前
858 Therapeutics' PARG Inhibitor ETX-19477 Shows 57% ORR in BRCA-Mutated Ovarian and Breast Cancer, Earns FDA Fast Track Designation
11个月前
Long-Term Survival Data Reinforce PARP Inhibitor Benefits in BRCA-Mutated Ovarian Cancer
6年前
PARP Inhibitors in Frontline Ovarian Cancer Treatment: A Review of Clinical Trials
8个月前
858 Therapeutics Receives FDA Fast Track Designation for PARG Inhibitor ETX-19477 in BRCA-Mutated Ovarian Cancer
2个月前
PARP Inhibitors Expand Beyond BRCA-Mutated Cancers: Emerging Evidence Across Solid Tumors and Combination Strategies
2个月前
Charting Intratumor Heterogeneity from Bench to Bedside: A Comprehensive Review
4年前
Advances in PARP Inhibitor Combinations Show Promise for Ovarian Cancer Treatment
第 1 页，共 1488 页
上一页
下一页
